Cellmid Limited is a limited by shares Australian public company. Located at NSW 2000 since 2018-06-07 the company is, as the updated on 2021-12-10 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2004-10-08. Known company numbers for Cellmid Limited are as follows: ACN - 111304119, Australian Business Number - 69111304119. Cellmid Limited has been the company name since 2009-11-17. Their official company name changed on 2009-11-17 to Cellmid Limited. The company had used this name up until 2021-12-10. Additionally they had used Medical Therapies Limited from 2005-07-08 to 2009-11-17, Newbio Ltd from 2004-10-08 to 2005-07-08. This Australian public company was previously located in NSW 2000 (from 2014-09-19 to 2018-06-07), NSW 2000 (from 2013-06-18 to 2014-09-19), NSW 2000 (from 2008-02-15 to 2013-06-18). AUBiz found 2 trademarks that reference the abovementioned company. 2007-02-14 is the date the documents needed to start the registration process of trademark no 1161734 were submitted. This trademark is categorised as "word" and its application status is "registered, live". Other company trademarks include trademark number 1162114, application status "registered, live", registered on 2007-02-19 in the "word" category.
| Status | From | To |
|---|---|---|
| Active | 2004-10-08 | current |
| Name | From | To |
|---|---|---|
| Anagenics Limited | 2021-12-10 | current |
| Cellmid Limited | 2009-11-17 | 2021-12-10 |
| Medical Therapies Limited | 2005-07-08 | 2009-11-17 |
| Newbio Ltd | 2004-10-08 | 2005-07-08 |
| Location | From | To |
|---|---|---|
| NSW 2000 | 2018-06-07 | current |
| NSW 2000 | 2014-09-19 | 2018-06-07 |
| NSW 2000 | 2013-06-18 | 2014-09-19 |
| NSW 2000 | 2008-02-15 | 2013-06-18 |
| NSW 2113 | 2007-07-07 | 2008-02-15 |
| NSW 2113 | 2006-11-28 | 2007-07-07 |
| NSW 2000 | 2004-10-08 | 2006-11-28 |
| Status | From | To |
|---|---|---|
| Registered | 2004-10-08 | current |
Advertisements
| Application date: | 2007-02-14 |
| Lodgement date: | 2007-02-14 |
| Registered date: | 2007-02-14 |
| Live or dead: | Live |
| CPI status: | Registered |
| Status: | Registered/Protected |
| Mark code: | Trade Mark |
| Trademark type: | Word |
| Acceptance due date: | 2007-05-28 |
| Sealing due date: | 2007-12-07 |
| Registered from date: | 2007-02-14 |
| Sealing date: | 2007-11-08 |
| Renewal due date: | 2017-02-14 |
| Court orders: | No |
| Revocation of the acceptance: | No |
| Lodgement type: | National |
| Descriptive: | Cuprindo |
| Examination report number: | 1 |
| Examination class count: | 2 |
| NICE class code: | 5 |
| NICE occ number: | 1 |
| NICE description text: | Pharmaceutical And Veterinary Preparations Including Anti-cancer Preparations And Anti-inflammatory Preparations; Preparations For Treatment Of Diabetic, Cardiovascular And Skin Diseases And Conditions; Non-steroidal Anti-inflammatory Drugs And Preparations Containing Non-steroidal Anti-inflammatory Drugs; Metal Complexes For Pharmaceutical And Veterinary Use; Medicaments Containing Metal Complexes For Treatment Of Cancer, Inflammation, Wounds And Burns |
| Suburb name: | Sydney |
| Postcode: | 2000 |
| Australian state code: | NSW |
| Country code: | AU |
| Attorney code: | 338844 |
| Agency code: | EY |
| Transaction type: | Address for service of the trademark |
| Suburb name: | Hornsby |
| Postcode: | 2077 |
| Australian state codee: | NSW |
| Attorney type: | Attorney |
| Country code: | AU |
| Application date: | 2007-02-19 |
| Lodgement date: | 2007-02-19 |
| Registered date: | 2007-02-19 |
| Live or dead: | Live |
| CPI status: | Registered |
| Status: | Registered/Protected |
| Mark code: | Trade Mark |
| Trademark type: | Word |
| Acceptance due date: | 2007-06-05 |
| Sealing due date: | 2007-12-14 |
| Registered from date: | 2007-02-19 |
| Sealing date: | 2007-12-12 |
| Renewal due date: | 2017-02-19 |
| Court orders: | No |
| Revocation of the acceptance: | No |
| Lodgement type: | National |
| Descriptive: | Dermindo |
| Examination report number: | 1 |
| Examination class count: | 2 |
| NICE class code: | 5 |
| NICE occ number: | 1 |
| NICE description text: | Pharmaceutical And Veterinary Preparations Including Anti-cancer Preparations And Anti-inflammatory Preparations; Preparations For Treatment Of Skin Diseases And Conditions; Non-steroidal Anti-inflammatory Drugs And Preparations Containing Non-steroidal Anti-inflammatory Drugs; Metal Complexes For Pharmaceutical And Veterinary Use; Medicaments Containing Metal Complexes For Treatment Of Cancer, Inflammation, Wounds And Burns |
| Suburb name: | Sydney |
| Postcode: | 2000 |
| Australian state code: | NSW |
| Country code: | AU |
| Attorney code: | 338844 |
| Agency code: | EY |
| Transaction type: | Address for service of the trademark |
| Suburb name: | Hornsby |
| Postcode: | 2077 |
| Australian state codee: | NSW |
| Attorney type: | Attorney |
| Country code: | AU |
International Patent Classification:
| IPC Mark: | C12N 15/19 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering |
| Subclass code: | N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) |
| Main group code: | 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k) |
| Subgroup code: | 19 - interferons; lymphokines; cytokines |
IP Australia process information:
| Expiry date: | 2019-08-24 |
General information:
| Patent status: |
Sealed What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical. |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | A61K 39/395 |
| Section code: | A - human necessities |
| Class code: | 61 - medical or veterinary science; hygiene |
| Subclass code: | K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l) |
| Main group code: | 39 - medicinal preparations containing antigens or antibodies (materials for immunoassay g01n0033530000) |
| Subgroup code: | 395 - antibodies (agglutinins a61k0038360000); immunoglobulins; immune serum, e.g. antilymphocytic serum |
IP Australia process information:
| Expiry date: | 2027-11-13 |
General information:
| Patent status: |
Lapsed Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months). |
| Patent type: | NPE |
International Patent Classification:
| IPC Mark: | C07D 209/28 |
| Section code: | C - chemistrymetallurgy |
| Class code: | 7 - organic chemistry |
| Subclass code: | D - heterocyclic compounds (macromolecular compounds c08) |
| Main group code: | 209 - heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom |
| Subgroup code: | 28 - 1-(4-chlorobenzoyl)-2-methyl- indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; esters thereof |
IP Australia process information:
| Expiry date: | 2026-03-24 |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.